Teachers Advisors LLC lifted its position in shares of Amedisys Inc (NASDAQ:AMED) by 2.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 79,605 shares of the health services provider’s stock after buying an additional 2,124 shares during the quarter. Teachers Advisors LLC owned approximately 0.24% of Amedisys worth $5,000,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of AMED. BlackRock Inc. grew its holdings in shares of Amedisys by 2,877.7% during the first quarter. BlackRock Inc. now owns 5,676,870 shares of the health services provider’s stock worth $290,032,000 after buying an additional 5,486,225 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Amedisys by 662.7% during the second quarter. Russell Investments Group Ltd. now owns 276,808 shares of the health services provider’s stock worth $17,387,000 after buying an additional 240,513 shares in the last quarter. FMR LLC grew its holdings in shares of Amedisys by 6.9% during the first quarter. FMR LLC now owns 2,352,632 shares of the health services provider’s stock worth $120,196,000 after buying an additional 152,632 shares in the last quarter. MARSHALL WACE ASIA Ltd purchased a new stake in shares of Amedisys during the first quarter worth about $5,361,000. Finally, Marshall Wace North America L.P. purchased a new stake in shares of Amedisys during the first quarter worth about $5,361,000. Institutional investors and hedge funds own 96.55% of the company’s stock.
Shares of Amedisys Inc (NASDAQ AMED) opened at 47.77 on Wednesday. The company has a 50 day moving average of $51.97 and a 200 day moving average of $55.24. The firm has a market capitalization of $1.62 billion, a PE ratio of 40.83 and a beta of 0.87. Amedisys Inc has a 52-week low of $34.58 and a 52-week high of $65.91.
AMED has been the subject of a number of recent research reports. BidaskClub downgraded shares of Amedisys from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 12th. Mizuho downgraded shares of Amedisys from a “buy” rating to a “neutral” rating and set a $50.00 price target for the company. in a report on Wednesday, July 26th. Bank of America Corporation initiated coverage on shares of Amedisys in a report on Monday, August 21st. They set a “neutral” rating and a $55.00 price target for the company. Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $60.00 price target on shares of Amedisys in a report on Friday, September 15th. Finally, Robert W. Baird reiterated a “hold” rating and set a $50.00 price target on shares of Amedisys in a report on Wednesday, October 4th. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $55.90.
COPYRIGHT VIOLATION WARNING: “Teachers Advisors LLC Purchases 2,124 Shares of Amedisys Inc (AMED)” was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.com-unik.info/2017/10/11/teachers-advisors-llc-purchases-2124-shares-of-amedisys-inc-amed.html.
In other news, insider David B. Pearce sold 1,000 shares of the company’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $50.00, for a total value of $50,000.00. Following the transaction, the insider now owns 10,488 shares in the company, valued at approximately $524,400. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bruce D. Perkins bought 2,000 shares of the company’s stock in a transaction dated Thursday, August 3rd. The stock was acquired at an average price of $46.60 per share, for a total transaction of $93,200.00. Following the acquisition, the director now directly owns 15,825 shares in the company, valued at $737,445. The disclosure for this purchase can be found here. 2.00% of the stock is owned by corporate insiders.
Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.
What are top analysts saying about Amedisys Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Amedisys Inc and related companies.